Skip to main content
Premium Trial:

Request an Annual Quote

US Gov t Awards Schott $1M to Develop Microarray Platform for Pathogen Detection ...

NEW YORK, Feb. 14 (GenomeWeb News) - The US government has allotted $1 million of its defense appropriations bill to Schott North America to develop a microarray-based platform for detecting biological agents, Schott said recently.


According to Duryea, Penn.-based Schott NA, the funding was secured through the offices of Congressman Paul Kanjorksi (D-Penn.).  Schott will collaborate with the University of Scranton's Institute of Molecular Biology and Medicine to develop the fully automated and multiplexed microarray platform, the company said.


The new platform would be a 96-well microarray, with the potential to screen for up to 2,000 pathogens in each well, Schott said.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.